A methylome-based score to predict survival after regorafenib in recurrent glioblastoma.

Saved in:
Bibliographic Details
Title: A methylome-based score to predict survival after regorafenib in recurrent glioblastoma.
Authors: Chiesa S; Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Miele E; Department of Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Patrizi S; Department of Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Pedace L; Department of Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Mazzarella C; Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Offi M; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Martino A; Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Falchetti ML; Institute of Biochemistry and Cell Biology, IBBC-CNR, Rome, Italy., Di Monaco G; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Russo R; Department of Radiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Vinciarelli F; Department of Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Mastronuzzi A; Department of Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Gaudino S; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.).; Department of Radiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Martini M; Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', Section of Pathology, University of Messina, Messina, Italy., Ricci-Vitiani L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Pallini R; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Lauretti L; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Gambacorta MA; Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Locatelli F; Department of Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Olivi A; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.)., Gessi M; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.).; Department of Pathology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., D'Alessandris QG; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; School of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy (M.O., G.D.M., S.G., L.L., M.A.G., F.L., A.O., M.G., Q.G.D.).
Source: Neuro-oncology advances [Neurooncol Adv] 2026 Apr 30; Vol. 8 (1), pp. vdag108. Date of Electronic Publication: 2026 Apr 30 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-2498
DOI:10.1093/noajnl/vdag108